Timing is everything for 5AM Ventures, which said Tuesday that it raised $250 million for its fourth fund financing. Read the full story
Timing is everything for 5AM Ventures, which said Tuesday that it raised $250 million for its fourth fund financing. Read the full story
OrbiMed announced the closing of its next venture capital financing with just over $735 million in commitments.
Ina private financing venture, S3 Ventures has raised a $75 million fund to invest in information technology and medical device companies Read the full story
New Enterprise Associates has closed one of the largest venture funds financing ever raised at $2.6 billion Read the full story
A newsletter from Life Science Ventures - issue 2 - March 2012.
NatCure Sciences, a biotech startup looking to set up offices in Cambridge or Boston this year, is seeking to raise venture funds this quarter as it works to develop a treatment that would rival a standard anti-inflammatory drug on the market. Read the full story
As Rainbow BioSciences, the biotech division of Rainbow Coral Corp., continues to vet investment banks to assist with its capital raise, investors remain optimistic on the returns that new biotech firms can bring. A recent report indicates that venture capital investments in biotech increased by 22 percent to $4.7 billion last year. Read the full story
Published by MassDevice.
Venture capital investors spent 21% more backing life science startups in 2011 than in 2010, according to PricewaterhouseCoopers; also, VCs in the Valley lose confidence; Greenway Medical prices IPO; does Abbott need a new CEO?; and analysts' ups and downs. Read the full story
Steve Holtzman got his first taste of corporate venture capital back in 1987, when he raised money from SR One, back when it was part of an old company known as Smith, Kline & French Read the full story
Canaan Partners has announced a new $600 million fund of which one-third will be dedicated to medical device, biopharmaceuticals and diagnostics investing. Read the full story